Early Start Denver Model vs Pivotal Response Treatment for Autism
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines two autism treatments, the Early Start Denver Model (ESDM) and Pivotal Response Treatment (PRT), to determine which most effectively improves communication skills in young children with autism. After completing one of these programs, some children may also try a home-based therapy called Developmental Reciprocity Treatment (DRT). The trial targets children aged 2 to 4 years and 11 months with autism and significant language delays, requiring a parent to participate in training sessions. Participants will attend one of the therapies four days a week for 24 weeks and undergo regular assessments throughout the study. The goal is to identify which treatment works better for different children. As an unphased trial, this study provides families with a unique opportunity to explore innovative therapies that could significantly enhance their child's communication skills.
Will I have to stop taking my current medications?
The trial requires that participants have been on stable medications for at least one month before starting and do not change them during the study.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Previous studies have shown that both the Early Start Denver Model (ESDM) and Pivotal Response Treatment (PRT) are safe and beneficial for young children with autism. Research indicates that ESDM, a play-based therapy, uses familiar activities to enhance communication and social skills in autistic children. Evidence shows it is generally well-tolerated, with no major safety concerns reported.
Similarly, PRT improves social communication through play and is known for its safety and adaptability to each child's needs. This approach is typically well-tolerated, with studies highlighting its effectiveness without significant negative effects.
For the Developmental Reciprocity Treatment (DRT), research suggests it is a promising new approach. While detailed safety data remains limited, initial findings show it effectively supports social development. Most parents in DRT-based studies have met training goals, indicating a positive safety and effectiveness profile.
Overall, these interventions are considered safe and well-tolerated for children with autism.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for autism because they offer innovative approaches to improving social and communication skills. The Early Start Denver Model (ESDM) is unique because it integrates play-based activities with developmental and behavioral strategies, encouraging learning in a natural setting. Pivotal Response Treatment (PRT) focuses on motivation and self-management, using a child’s interests to promote learning, which is different from more traditional, structured therapies. Developmental Reciprocity Treatment (DRT) emphasizes building emotional connections and reciprocal interactions, aiming to enhance social engagement. These methods stand out from standard options by fostering skills through everyday interactions and play, potentially leading to more natural and sustained improvements.
What evidence suggests that this trial's treatments could be effective for improving communication skills in young children with autism?
Research has shown that the Early Start Denver Model (ESDM), one of the treatments in this trial, helps young children with autism improve their thinking skills, language, and social interactions. Studies have found that children receiving ESDM develop better thinking and language skills compared to other treatments. Similarly, Pivotal Response Treatment (PRT), another treatment option in this trial, improves social communication in children with autism. Data indicates that many children receiving PRT initiate conversations more often and communicate more effectively. Both ESDM and PRT have strong evidence supporting their effectiveness, making them promising options for enhancing communication skills in children with autism.12367
Who Is on the Research Team?
Antonio Hardan, MD
Principal Investigator
Stanford University
Grace Gengoux, PhD
Principal Investigator
Stanford University
Are You a Good Fit for This Trial?
This trial is for children aged 2 to just under 5 years old who have been diagnosed with autism and have significant language delays. They must be able to participate in the study, not currently receive intensive in-home therapy, and have at least one English-speaking parent or caregiver available.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomly assigned to either ESDM or PRT for 24 weeks in a center-based program, attending treatment sessions 4 days per week (~3 hours/day), with developmental and autism assessments at baseline, 12 weeks, and 24 weeks, and weekly parent training sessions.
Follow-up
Participants complete follow-up assessments to monitor communication skills and developmental progress.
Optional Extension
Participants who meet specific clinical criteria may be offered home-based Developmental Reciprocity Treatment (DRT).
What Are the Treatments Tested in This Trial?
Interventions
- Developmental Reciprocity Treatment (DRT)
- Early Start Denver Model (ESDM)
- Pivotal Response Treatment (PRT)
Trial Overview
The study compares two center-based therapies—Early Start Denver Model (ESDM) and Pivotal Response Treatment (PRT)—to see which helps young children with autism improve communication skills. Children are randomly assigned to either ESDM or PRT for about six months.
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor
John and Marcia Goldman Foundation
Collaborator
Citations
Randomized Controlled Trial of Developmental Reciprocity ...
83% of parents in DRT-P met fidelity of implementation criteria by 24 weeks. ... Findings suggest DRT is a promising intervention for improving ...
4.4 A RANDOMIZED CONTROLLED TRIAL OF A ...
Conclusions: Preliminary results support the efficacy of DRT for improving some aspects of social communication development in young children with. ASD. These ...
Effectiveness of a Developmental Reciprocity Treatment ...
This is a research study examining the effectiveness of a Developmental Reciprocity Treatment Program (DRT-P) in treating social deficits in ...
4.
researchgate.net
researchgate.net/publication/392524100_Randomized_Controlled_Trial_of_Developmental_Reciprocity_Treatment_in_Young_Children_with_AutismRandomized Controlled Trial of Developmental Reciprocity ...
Thirty-seven children aged 2–5 years with ASD and language delay were randomized. 83% of parents in DRT-P met fidelity of implementation criteria by 24 weeks.
Randomized Controlled Trial of Developmental Reciprocity ...
Thirty-seven children aged 2-5 years with ASD and language delay were randomized. 83% of parents in DRT-P met fidelity of implementation criteria by 24 weeks.
Parent-Child Reciprocity and the Effectiveness of PEERS
The proposed study aims to examine the effect parent-teen reciprocity has on adolescents with an Autism Spectrum Disorder. Autism Spectrum Disorder (ASD) is a ...
ERIC - EJ1212232 - ERIC - Department of Education
This pilot study evaluated changes in parent behavior and child autism symptoms following a 12-week Developmental Reciprocity Treatment parent-training program.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.